European Stocks Tumble Amid Trade Uncertainty, Drug Trial Disappointment
European stocks closed lower today, pressured by renewed trade anxieties and disappointing pharmaceutical trial results. The Stoxx Europe 600 Index declined 0.5%, with financial services, media, and travel sectors underperforming.
Key factors influencing the market:
- Trade Tensions: President Trump’s latest tariff actions sparked confusion and prompted the European Parliament to suspend legislative work on the US trade deal.
- Novo Nordisk Setback: Shares of Novo Nordisk plummeted 16% after its CagriSema obesity drug underperformed Eli Lilly’s rival in trials.
- Company-Specific News: Johnson Matthey and Belimo Holding also experienced significant declines due to deal revisions and analyst concerns, respectively.
Leave a Reply